Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Adetola Kassim

3 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Treatment

    VICCBMT1567

    01/13/2017

    Multicenter Phase II, Double-blind Placebo Controlled Trial of Maintenance Ixazomib after Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Multiple Myeloma

    Treatment

    VICCBMT1566

    04/21/2016

    Continued, Long-Term Follow-Up and Lenalidomide Maintenance Therapy for Patients Who Have Enrolled on BMT CTN 0702

    Treatment

    VICCNCBMT12108

    05/08/2013

    A Non-Myeloablative Conditioning and Transplantation of Partially HLA-Mismatched and HLA-Matched Bone Marrow for Patients with Sickle Cell Disease and Other Hemoglobinopathies


    Print this page for your doctor